D.J. St. Germain’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.67M Sell
25,681
-339
-1% -$93.8K 0.2% 90
2026
Q1
$7.69M Sell
26,020
-94
-0.4% -$27.9K 0.3% 78
2025
Q4
$7.13M Sell
26,114
-434
-2% -$118K 0.28% 80
2025
Q3
$7.17M Buy
26,548
+94
+0.4% +$25.6K 0.29% 77
2025
Q2
$7.29M Buy
26,454
+275
+1% +$74.8K 0.31% 75
2025
Q1
$6.95M Sell
26,179
-421
-2% -$104K 0.33% 80
2024
Q4
$6.18M Sell
26,600
-218
-0.8% -$50.1K 0.28% 86
2024
Q3
$5.92M Sell
26,818
-2,459
-8% -$509K 0.27% 89
2024
Q2
$5.76M Buy
29,277
+314
+1% +$64.9K 0.28% 89
2024
Q1
$6.24M Buy
28,963
+940
+3% +$197K 0.3% 83
2023
Q4
$5.9M Buy
28,023
+4,483
+19% +$957K 0.31% 83
2023
Q3
$4.71M Sell
23,540
-2,809
-11% -$558K 0.26% 83
2023
Q2
$4.88M Buy
+26,349
New +$4.87M 0.26% 83
2022
Q4
$767K Buy
11,236
+9,069
+419% +$1.58M 0.26% 57
2022
Q3
$444K Hold
2,167
0.03% 160
2022
Q2
$444K Hold
2,167
0.03% 160
2022
Q1
$515K Sell
2,167
-226
-9% -$53.1K 0.03% 165
2021
Q4
$547K Hold
2,393
0.03% 162
2021
Q3
$463K Buy
2,393
+1
+0% +$203 0.03% 170
2021
Q2
$509K Buy
2,392
+90
+4% +$19K 0.03% 168
2021
Q1
$470K Sell
2,302
-7
-0.3% -$1.38K 0.03% 166
2020
Q4
$420K Buy
2,309
+6
+0.3% +$1.02K 0.03% 172
2020
Q3
$385K Sell
2,303
-52
-2% -$8.76K 0.03% 158
2020
Q2
$383K Sell
2,355
-50
-2% -$8.96K 0.03% 159
2020
Q1
$416K Sell
2,405
-520
-18% -$103K 0.04% 147
2019
Q4
$587K Hold
2,925
0.05% 137
2019
Q3
$618K Sell
2,925
-160
-5% -$33.4K 0.07% 112
2019
Q2
$599K Sell
3,085
-50
-2% -$9.22K 0.07% 110
2019
Q1
$516K Sell
3,135
-30
-0.9% -$5.3K 0.06% 115
2018
Q4
$595K Buy
3,165
+270
+9% +$49.9K 0.07% 109
2018
Q3
$493K Buy
2,895
+210
+8% +$35.4K 0.06% 118
2018
Q2
$440K Buy
2,685
+535
+25% +$87.4K 0.05% 116
2018
Q1
$348K Sell
2,150
-400
-16% -$63.7K 0.04% 127
2017
Q4
$372K Buy
2,550
+840
+49% +$120K 0.04% 117
2017
Q3
$232K Buy
+1,710
New +$216K 0.03% 137

Other funds holding CME

D.J. St. Germain's CME Position: Q2 2026 in Review

D.J. St. Germain reduced its CME Group (CME) stake by 1.3% in Q2 2026, selling an estimated $93.8K and leaving 25,681 shares worth $5.67M. The position accounts for 0.2% of the portfolio, ranked #90.

D.J. St. Germain first reported a position in CME in Q3 2017 and has held it in 35 quarters since. The position peaked at $7.69M in Q1 2026. 1,694 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • D.J. St. Germain held 25,681 shares of CME Group worth $5.67M as of Q2 2026.
  • D.J. St. Germain sold 339 CME Group shares in Q2 2026, an estimated $93.8K.
  • CME Group made up 0.2% of D.J. St. Germain's portfolio in Q2 2026, its #90 holding.
  • D.J. St. Germain first reported a position in CME Group in Q3 2017 and has held it in 35 quarters since.
  • D.J. St. Germain's CME Group position peaked at $7.69M in Q1 2026.
  • 1,694 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on D.J. St. Germain's 13F filing for Q2 2026, filed 21 Jul 2026.